Hi Reader, “We sometimes feel like a helpdesk”, the market access manager confessed, ‘but it’s mission impossible to keep track of all label extensions, changes to reimbursement criteria and upcoming launches for every possible competitor’. And she continued: “During holiday periods or with staff turnover, we get particularly stressed to keep track of all the information, stored in multiple Excel spreadsheets that need to be permanently updated and exchanged between colleagues”. In pharmaceutical companies, market access departments are often solicited as the central knowledge base for changes in competitor’s access timelines. However, thinking of the complex reimbursement landscape and ever-changing criteria for reimbursement of innovative products, consistently keeping up with all changes is draining highly-skilled staff. Exhaustively collecting all changes from EMA authorization to the latest change in reimbursement criteria would require a full time employee for your focus products, let alone the whole market. Since 2022, Digile has been serving many happy customers in the pharmaceutical industry with Farmanaut, a company-wide solution for data-driven pharma strategy, to relieve your company from this Herculean task. However, investing in Farmanaut is a no-brainer compared to the cost of hiring a part time collaborator, who could not even keep up with exhaustively monitoring all websites, databases and agendas. Market access departments implementing Farmanaut describe peace of mind: they can count on a central, updated knowledge base and have all information at hand for updates or strategic decisions. The convenience of the tool is appreciated by other colleagues as well. A commercial strategy manager once described it as follows:“ I was amazed by the simplicity of Farmanaut and immediately started following molecules. ” Farmanaut also provides advanced tools for market access strategy to alleviate the workflow:
Have a nice day, Team Farmanaut >> follow us on LinkedIn |
Want to learn how to easily integrate drug data, monitor changes and construct timelines for the European and Belgian drug market? Then subscribe to our newsletter and learn from our data experts. Nice to have you on board :-)
Hi Reader, "Hi, can we plan for a Farmaneut demo?" Farma-what? Farma-neut? As I started to visualize this new type of unhappy and somewhat grumpy medical professional, a wave of doubt made its way through my body. But soon thereafter, a warm feeling of thriving ambition made its way back to me, producing a big smile on my face. We love our customers for their enthusiasm but far underestimated their creativity. When developing market intelligence software, we felt like astronauts exploring...
Hi Reader, Do you remember the days you were buildling houses in Lego bricks? Building the house of your dreams, but then getting frustrated as you couldn't find that specific 3-dotted thin brick you needed according to plan? Of having to start it all over because you skipped that one crucial step? Or did you prefer to play around, ignoring any provided plan? And now, as an adult? Do you build your dream house brick by brick, working yourself to blood sweat and tears? Or do you consult an...
Hi Reader, “It’s not about creating a digital strategy for our business but about creating a business strategy for a digital world.” A quote from Lidia Fonseca. As Pfizer’s Chief Digital and Technology Officer, Lidia is responsible for all data and technology solutions across the organization. Organizations need to adapt to the changing environment and implement digital and data in their everyday operations and workflow. But I hear you think… where do I start? I’m already using data, right?...